These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38088172)

  • 1. Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria.
    Jörg L; Müller-Wirth N; Kammermann K; Stalder O; Pichle W; Hausmann O
    Eur Ann Allergy Clin Immunol; 2023 Dec; ():. PubMed ID: 38088172
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study.
    Schoepke N; Asero R; Ellrich A; Ferrer M; Gimenez-Arnau A; E H Grattan C; Jakob T; Konstantinou GN; Raap U; Skov PS; Staubach P; Kromminga A; Zhang K; Bindslev-Jensen C; Daschner A; Kinaciyan T; Knol EF; Makris M; Marrouche N; Schmid-Grendelmeier P; Sussman G; Toubi E; Church MK; Maurer M
    Allergy; 2019 Dec; 74(12):2427-2436. PubMed ID: 31228881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not ViceVersa.
    Xiang YK; Kolkhir P; Scheffel J; Sauer M; Vera C; Frischbutter S; Krause K; Siebenhaar F; Metz M; Maurer M; Altrichter S
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2417-2425.e1. PubMed ID: 36805105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria.
    Endo T; Toyoshima S; Hayama K; Tagui M; Niwa Y; Ito M; Terui T; Okayama Y
    Asia Pac Allergy; 2020 Apr; 10(2):e12. PubMed ID: 32411577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution.
    Deza G; March-Rodríguez A; Sánchez S; Ribas-Llauradó C; Soto D; Pujol RM; Gimeno R; Giménez-Arnau AM
    J Allergy Clin Immunol Pract; 2019; 7(5):1619-1626.e1. PubMed ID: 30685572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.
    Izaki S; Toyoshima S; Endo T; Kanegae K; Nunomura S; Kashiwakura JI; Sasaki-Sakamoto T; Nakamura R; Akiyama H; Ra C; Hayama K; Terui T; Okayama Y
    Allergol Int; 2019 Jul; 68(3):342-351. PubMed ID: 30803853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE.
    Kolkhir P; Kovalkova E; Chernov A; Danilycheva I; Krause K; Sauer M; Shulzhenko A; Fomina D; Maurer M
    J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4138-4146.e8. PubMed ID: 34363991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel detection method for cross-linking of IgE-receptors by autoantibodies in chronic spontaneous urticaria.
    Koga Y; Yokooji T; Ogino R; Taogoshi T; Takahagi S; Ishii K; Chinuki Y; Morita E; Hide M; Matsuo H
    Allergol Int; 2022 Jan; 71(1):94-102. PubMed ID: 34465532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review.
    Moñino-Romero S; Hackler Y; Okas TL; Grekowitz EM; Fluhr JW; Hultsch V; Kiefer LA; Pyatilova P; Terhorst-Molawi D; Xiang YK; Siebenhaar F; Maurer M; Kolkhir P
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2411-2416. PubMed ID: 37286132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.
    Rauber MM; Pickert J; Holiangu L; Möbs C; Pfützner W
    Allergy; 2017 Dec; 72(12):1904-1911. PubMed ID: 28585360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab.
    Maronese CA; Ferrucci SM; Moltrasio C; Lorini M; Carbonelli V; Asero R; Marzano AV; Cugno M
    J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615181
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Responsiveness of Basophils via FcεRI Reflects Disease Activity in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2019; 7(8):2835-2844.e7. PubMed ID: 31136822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.
    Alizadeh Aghdam M; Knol EF; van den Elzen M; den Hartog Jager C; van Os-Medendorp H; Knulst AC; Otten HG; Röckmann H
    Clin Exp Allergy; 2020 Mar; 50(3):364-371. PubMed ID: 31925825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of Autologous Whole Blood Injection Efficacy in Patients with Chronic Spontaneous Urticaria with Autoreactivity: A Preliminary Study.
    Chen Q; Luo J; Yang X; Chen W; Liu W; Song Z
    Int Arch Allergy Immunol; 2024; 185(2):190-195. PubMed ID: 37952519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
    Vonakis BM; Vasagar K; Gibbons SP; Gober L; Sterba PM; Chang H; Saini SS
    J Allergy Clin Immunol; 2007 Feb; 119(2):441-8. PubMed ID: 17125820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.
    Giménez-Arnau AM; Ribas-Llauradó C; Mohammad-Porras N; Deza G; Pujol RM; Gimeno R
    Clin Transl Allergy; 2022 Feb; 12(2):e12117. PubMed ID: 35126995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.
    Jörg L; Pecaric-Petkovic T; Reichenbach S; Coslovsky M; Stalder O; Pichler W; Hausmann O
    Clin Exp Allergy; 2018 Feb; 48(2):196-204. PubMed ID: 29164723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.
    Sabroe RA; Fiebiger E; Francis DM; Maurer D; Seed PT; Grattan CE; Black AK; Stingl G; Greaves MW; Barr RM
    J Allergy Clin Immunol; 2002 Sep; 110(3):492-9. PubMed ID: 12209101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
    Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
    Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.